Professional
Added to YB: 2024-08-15
Pitch date: 2024-06-30
MDT [bullish]
Medtronic plc
+29.76%
current return
Author Info
No bio for this author
Company Info
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.
Market Cap
$128.0B
Pitch Price
$75.31
Price Target
N/A
Dividend
2.84%
EV/EBITDA
15.09
P/E
27.06
EV/Sales
4.29
Sector
Health Care Equipment and Supplies
Category
turnaround
Matrix Asset Advisors New Portfolio Holding: Medtronic plc
MDT: World's largest implantable biomedical device maker. 37% cardiovascular, 29% neuroscience, 26% medical surgical, 8% diabetes. 49% int'l sales. COVID-19 impact, but recent improvement. Earnings peaked 2018, now ~$5/share. Down from $135 in 2022, now ~$80. Compelling valuation, reaccelerating earnings growth. Significant upside potential.
Read full article (1 min)